Freebird Partners LP

Insider Reports History

Entity
Company
Location
2800 Post Oak Blvd., Suite 2000, Houston, TX
Signature
Freebird Partners LP, By: Freebird Investments LLC, its general partner, By: /s/ Curtis W. Huff, Chairman and President
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Freebird Partners LP:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eterna Therapeutics Inc. 10%+ Owner Convertible Note Shares 783K $1.5M $1.92 Dec 15, 2023 Direct
Comera Life Sciences Holdings, Inc. 10%+ Owner Convertible Note Shares 2.45M $135K $0.06 Dec 29, 2023 Direct
Comera Life Sciences Holdings, Inc. 10%+ Owner Common Stock Purchase Warrant 7.36M Dec 29, 2023 Direct
Eterna Therapeutics Inc. 10%+ Owner Common Stock Purchase Warrant 1.99M Dec 15, 2023 Direct
Comera Life Sciences Holdings, Inc. 10%+ Owner Common Stock, par value $0.0001 per share 1.25M Dec 3, 2023 Direct

Insider Reports Filed by Freebird Partners LP

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CMRA Comera Life Sciences Holdings, Inc. Dec 29, 2023 2 $135K 4 Jan 3, 2024 10%+ Owner
ERNA Eterna Therapeutics Inc. Dec 14, 2023 6 $1M 4 Dec 18, 2023 10%+ Owner
CMRA Comera Life Sciences Holdings, Inc. Dec 3, 2023 0 $0 3 Jan 3, 2024 10%+ Owner
ERNA Eterna Therapeutics Inc. Jul 14, 2023 2 $750K 4 Jul 18, 2023 10%+ Owner
ERNA Eterna Therapeutics Inc. Apr 3, 2023 0 $0 3 Apr 4, 2023 10%+ Owner